Advertisement

HCV Website Offers Expert Advice, Guidelines on Treatment — Physician’s First Watch

Medical News |
January 30, 2014

HCV Website Offers Expert Advice, Guidelines on Treatment

By Joe Elia

A website designed to help physicians treat the estimated 3 to 4 million Americans with hepatitis C infection has made its debut.

Clinicians from the sponsoring organizations — the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America, and the International Antiviral Society-USA — stress the ability of new direct-acting antivirals, such as simeprevir and sofosbuvir, to cure most patients. However, because there aren't enough specialists to treat all known cases, the hope is that more gastroenterologists and primary care clinicians will begin using these new regimens, given their improved tolerability.

A summary of the supporting evidence (and the quality of that evidence) follows each recommendation. The site does not address treatment costs.

Reader Comments (1)

Rosslyn Ngugi Resident, Internal Medicine, kenyatta national hospital

looking forward to learning new insights into management of HCV

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement